Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2025-11-17 00:00:00 ET · period of report 2025-11-13 · accession 0001720568-25-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-17 | 2025-11-13 | ANIP | Walsh Patrick D | Dir | G - Gift | $0.00 | -3,000 | 58.4K | -5% | $0 | |
| 2025-11-17 | 2025-11-13 | ANIP | Walsh Patrick D | Dir | S - Sale | $86.88 | -8,643 | 61.4K | -12% | -$750.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-13 | G | D | 3,000 | $0.00 | 58,405 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-13 | S | D | 8,643 | $86.88 | 61,405 | D | — | — | (F1) The shares were sold in multiple trades at prices ranging from $86.15 to $87.80. The price reported above reflects the weighted average sales price. |